Company Description
The Scripps System™ is a Platform as a service (PaaS) Solution to keep pharmaceuticals secure within the lawful supply chain.
This solution will deliver new releases of expanded features and functions made available on a yearly subscription revenue model.
The Scripps System™ currently includes the availability of secure storage (vaults and safes) and access control system management available now on a transaction-based revenue model.
New solution features are scheduled to be released in 2023 and 2024 and will include advanced inventory management, supply chain tracking, audit/tracking capability, diversion control, advanced analytics, and application programming interfaces to common healthcare applications which will be made available on the subscription revenue model.
Scripps Safe, Inc. plans to primarily focus on three major verticals, mobile pharmaceutical delivery including Fire-EMS; Private Ambulance operations/ home healthcare delivery; and Addiction or Medication Treatment Facilities by launching solutions with a yearly subscription recurring revenue model.
These verticals represent the pharmaceutical distribution supply chain from manufacturers through distributors down to care providers.
Scripps Safe was honored to be chosen as a 2021 EMS World Innovations Award Winner for the Scripps System™, a Drug Enforcement Agency and Drug Supply Chain Security Act compliance inventory audit and tracking solution.
Scripps Safe currently has over 600 healthcare clients who have purchased DEA compliant vaults and safes.
Country | United States |
Founded | 2012 |
Industry | Health Care |
Sector | Health Care Technology |
CEO | Jacqueline von Zwehl |
Contact Details
Address: 9051 Tamiami Trail N, Suite 201 Naples, FL 34108 United States | |
Phone | (844) 472-3379 |
Website | 4saferx.com |
Stock Details
Ticker Symbol | SSAI |
Exchange | BATS |
Fiscal Year | January - December |
Reporting Currency | USD |
IPO Price | $5.00 |
CIK Code | 0001912498 |
Employer ID | 88-0611514 |
SIC Code | 7372 |
Key Executives
Name | Position |
---|---|
Jacqueline von Zwehl | Chief Executive Officer, Chairman of the Board of Directors and Director |
Craig Steinhoff | Chief Financial Officer |
James Egan | Director, Audit Chair, Independent Board |
Tim Theriault | Director, Human Capital and Compensation Chair, Independent Board |
Steven Ruhl | Director, Independent Board |
Doug Balog | Director, Nominating & Governance Chair, Independent Board |
Latest SEC Filings
Date | Type | Title |
---|---|---|
May 31, 2024 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
Apr 9, 2024 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
Jan 30, 2024 | FWP | Free Writing Prospectus |
Jan 26, 2024 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
Jan 5, 2024 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
Nov 27, 2023 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
Nov 16, 2023 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
Nov 2, 2023 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
Oct 16, 2023 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
Sep 14, 2023 | FWP | Free Writing Prospectus |